Dopamine agonist withdrawal syndrome: The apomorphine solution

Archives of Neurology

Volumn 67, Issue 9, 2010, Pages 1155-

  Schlesinger, Ilana ^a   Erikh, Ilana ^a   Zaaroor, Menashe ^a  

^a Rambam Health Care Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

BRAIN DEPTH STIMULATION; CLINICAL PROTOCOL; DRUG DOSE TITRATION; DRUG WITHDRAWAL; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME; SUBSTANCE WITHDRAWAL SYNDROME;

APOMORPHINE; DOPAMINE AGONISTS; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77957086181     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.220     Document Type: Letter

References (2)

1. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. 2010;67(1):58-63.
2. Fine J, Duff J, Chen R, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med. 2000;342(23):1708- 1714. (Pubitemid 30354518)